Pharmalicensing.com
Latest: Watch here for details of new products and services.
RSS Feeds
Advanced search

Login  Register

Our Products
Overview
Partnering Search
Company Profiling
Partneringtools
Reports
Partnering Consulting
Comparison
 
Forums
Visit our forums
 
Jobs
Visit our job site
 
Case Studies
See what others think about our service
 
Newsletter
Partnering update
Key reports
Subscribe
 
Quick Links
Profile now
Register now
Profiled companies
Featured events
Industry news
PR Newswire New!
 
Contact us
Send an email
Call us: +44 1904 520460
Request a callback
 
RSS Feeds
Keep up to date

Pharmalicensing Ltd
is a division of
UTEK Corporation
Out-licensing

Adamantane Analogues

Specific to cell susceptible to HIV infection

Full description

Summary
Adamantane is a chemical with a unique symmetrical rigid structure that has been used in the past to modify an amino group to work as an anti-viral against certain strains of Influenza-A. However, little investigation has been done for the base compound and other antiviral effects it may have. Researchers at the University of Nebraska Medical Center have developed new adamantine analogues that comprise a non-toxic water-soluble anionogenic polymer carrier that can be used to specifically direct the compound to host cells. Data indicates that this invention can inhibit an HIV 1 infection in lymphoblastoid cells.

Market Value
HIV 1 infections are a worldwide problem, and treatments for the disease are often toxic to the patient. The use of the adamantane analogues provides a promising new treatment that would be beneficial to millions.

Features and Benefits

  • Non-toxic
  • Anti-viral activity in more then one cell type
  • Specific to cell susceptible to HIV infection

Development status

Early Stage

Patent information

Patent issued (5,880,154)

TID 02

Type of business relationship sought

UNeMed Corporation offers a variety of licensing options and collaborative development opportunities with University of Nebraska Medical Center.

Licensing contact

Steve Schreiner
Sr. Licensing Associate
Request more information

More information

For more information about the product please visit website.

Company details

University of Nebraska Medical Center / UNeMed Corporation
Technology Marketing and Licensing for The University of Nebraska Medical Center

Related reports

Are you looking for reports related to this particular subject. Our Reports section is the best place to start.

Related items

Related categories

Partnering consultation free of charge
Therapeutic Area Partnerships
Industry news: Pharmalicensing provides comprehensive industry coverage.

© Copyright 1995-2008 Pharmalicensing Ltd, is a division of UTEK Corporation All rights reserved. Terms and Conditions | Site map | Contact us